This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key takeaways: You can get semaglutide injections (Ozempic® and Wegovy®) ...
Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability ...
Imagine reaching for your daily medication, only to learn it could be putting your health at risk. That's the reality facing ...
US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...
A global analysis of 125 turmeric supplements across five major markets revealed widespread inconsistencies in labeling, ...
KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...
Enforcement action will be taken against any company marketing the products for children under the age of 3 or who are at low or moderate risk for tooth decay.
Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in ...
Opinion
A sports device to ‘protect the brain’ illustrates a major problem with the FDA de novo pathway
This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...
The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.
CHICAGO >> President Donald Trump’s embrace of an old generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms has triggered a surge in demand from parents who ...
The dismissal of a lawsuit challenging "climate neutral" labeling claims, a European ban on "meat" names for plant-based foods, a letter urging FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback